When Dr Ben Goldacre recently voiced concerns in the British Medical Journal about drug companies ‘engineering’ drug trials, resulting in what he called “bad evidence, which distorts medical decision-making, and harms patients”, we only have to look at the Champix fiasco to see how true that is. But that is not the only type [...]

Filed under: Champix/Chantix, Drugs on Trial, Publicity, The Campaign by Chris
11 Comments »